ArticleCancers2022

Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months.

David Zahrieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.